{"id":146247,"date":"2023-05-16T03:45:00","date_gmt":"2023-05-16T07:45:00","guid":{"rendered":"https:\/\/44.250.171.167\/?p=146247"},"modified":"2023-05-16T06:14:41","modified_gmt":"2023-05-16T10:14:41","slug":"earnings-summary-of-granules-india-limited-for-q4-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q4-fy23\/","title":{"rendered":"Earnings Summary Of Granules India Limited For Q4 FY23"},"content":{"rendered":"<p>Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). With a strong focus on quality, innovation, and customer satisfaction, Granules India has established itself as a reliable player in the pharmaceutical industry. The company&#8217;s primary segment is the manufacturing of APIs, which are the essential components of pharmaceutical drugs.<\/p>\n<ul>\n<li>Granules India Limited reported Total Income for Q4 FY23 of \u20b91,198.87 Crore up from \u20b91,033.93 Crore year on year, a growth of 16%.<\/li>\n<li>Total Expenses for Q4 FY23 of \u20b91,034.89 Crore up from \u20b9883.81 Crore year on year, a growth of 17.1%.<\/li>\n<li>Consolidated Net Profit of \u20b9119.60 Crore, up 7.7% from \u20b9111 Crore in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b94.93, from \u20b94.46 in the same quarter of the previous year.<\/li>\n<\/ul>\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"640\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5-1024x640.png\" alt=\"\" class=\"wp-image-146248\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5-1024x640.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5-300x187.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5-768x480.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5-1536x960.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5-2048x1280.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). With a strong focus on quality, innovation, and customer satisfaction, Granules India has established itself as a reliable player in the pharmaceutical [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-146247","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":141857,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q3-fy23\/","url_meta":{"origin":146247,"position":0},"title":"Earnings Summary Of Granules India Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 15, 2023","format":false,"excerpt":"Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has grown to become a leading producer of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulations, and other healthcare products. Revenue from Operations was \u20b91,146 Cr, up 15% year on year,\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-13.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":146250,"url":"https:\/\/alphastreet.com\/india\/granules-india-limited-q4-fy23-net-profit-increased-by-8\/","url_meta":{"origin":146247,"position":1},"title":"Granules India Limited Q4 FY23; Net Profit Increased By 8%","author":"Hardik Bhandare","date":"May 16, 2023","format":false,"excerpt":"Granules India Limited reported Total Income for Q4 FY23 of \u20b91,198.87 Crore up from \u20b91,033.93 Crore year on year, a growth of 16%. Consolidated Net Profit of \u20b9119.60 Crore, up 7.7% from \u20b9111 Crore in the same quarter of the previous year. The Earnings per Share is \u20b94.93, from \u20b94.46\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/89bc58e2-5fd0-4dd5-a069-83ba05e9b926.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172455,"url":"https:\/\/alphastreet.com\/india\/granules-india-q2-fy26-earnings-results\/","url_meta":{"origin":146247,"position":2},"title":"Granules India Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 18, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries, specializing in Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, posted impressive financial results for Q2FY26. Financial Highlights: Revenues increased 34.13% year-on-year to \u20b91,297 crore from \u20b9967 crore. Total expenses rose 33.02% to \u20b91,120 crore from \u20b9842 crore. Consolidated net profit\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147094,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-dishman-carbogen-amcis-limited-for-q4-fy23\/","url_meta":{"origin":146247,"position":3},"title":"Earnings Summary Of Dishman Carbogen Amcis Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 23, 2023","format":false,"excerpt":"Dishman Carbogen Amcis Limited is a global pharmaceutical contract development and manufacturing organization (CDMO) that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialized drug products. With over three decades of experience, the company has established itself as a trusted partner for pharmaceutical companies worldwide.\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166823,"url":"https:\/\/alphastreet.com\/india\/granules-india-ltd-q3fy25-6-fall-in-profits\/","url_meta":{"origin":146247,"position":4},"title":"Granules India Ltd Q3FY25; 6% fall in Profits","author":"Divyansh_Kasana","date":"February 12, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. Financial Results: Granules India Ltd reported Revenues for Q3FY25 of \u20b91,138.00 Crores down from \u20b91,156.00 Crore year on year, a fall of 1.56%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/Y-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147519,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-industries-limited-for-q4-fy23\/","url_meta":{"origin":146247,"position":5},"title":"Earnings Summary Of Ipca Laboratories Industries Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 30, 2023","format":false,"excerpt":"Ipca Laboratories Limited is a leading pharmaceutical company headquartered in Mumbai, India. With over 75 years of experience, the company specializes in the development, manufacture, and marketing of a wide range of pharmaceutical products. Ipca Labs has a strong presence both in the domestic market of India and in several\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/146247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=146247"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/146247\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=146247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=146247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=146247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}